Search

Metastasis is responsible for about 9 of every 10 cancer deaths, and it remains one of the most daunting and least understood aspects of the disease. Researchers across MSK are approaching a wide variety of metastatic cancer types from many directions.

… Friday, June 6, 2025 Sometimes doctors say that people don’t die from cancer, they die from metastasis — that is, from the spread of cancer from an initial “primary” tumor to other parts of the body. “We know how to control primary tumors — with surgery, chemotherapy, and radiation,” says physician-scientist

For more than a decade, Memorial Sloan Kettering Cancer Center’s (MSK) Visible Ink writing program has given a voice to more than 3,000 people with cancer, allowing each of them a unique opportunity to express themselves through interpretive dance, music, and poetry.

… Wednesday, March 23, 2022 For more than a decade, Memorial Sloan Kettering Cancer Center’s (MSK) Visible Ink writing program has given a voice to more than 3,000 people with cancer, allowing each of them a unique opportunity to express themselves through interpretive dance, music, and poetry. On Monday

Therapies that target genetic alterations in tumors are showing promise for many cancer patients, but challenges in developing these new treatments remain.

… Thursday, February 9, 2017 Summary Three leaders in precision oncology at MSK have released a State of the Union-style report on where the field is going. Learn how we’re already helping people with cancer, and how we’re uniquely prepared to address the many challenges that still remain in the field.

Find tools for discussing a cancer diagnosis with your children.

… Tuesday, November 26, 2019 Summary There is no easy way to tell your child that you have cancer. However, there are ways to include them in the conversation and make sure they feel supported. Being diagnosed with cancer raises all sorts of questions. And if you’re a parent, you’re likely facing one question

Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the best cancer center in the northeast, the number two hospital for cancer care in the nation, and the number one hospital nationally for urology care by U.S. News & World Report in its annual Best Hospitals listing.

… Tuesday, August 1, 2023 Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the best cancer center in the northeast, the number two hospital for cancer care in the nation, and the number one hospital nationally for urology care by  U.S. News & World Report  in its annual Best Hospitals

Scientists at the Sloan Kettering Institute have discovered that the ability of cancers to metastasize to other organs is dependent upon their ability to co-opt natural wound-healing pathways. In a literal sense, metastasis is wound healing gone wrong. These findings provide a novel framework for thinking about metastasis and how to treat it.

… Monday, January 13, 2020 Bottom Line:  Scientists at the Sloan Kettering Institute have discovered that the ability of cancers to metastasize to other organs is dependent upon their ability to co-opt natural wound-healing pathways. In a literal sense, metastasis is wound healing gone wrong. These findings

Jae Park, MD, a hematologic oncologist and assistant attending physician at MSK, will present findings about the durability of CAR T cell therapy response in patients with relapsed B-cell acute lymphoblastic leukemia (B-ALL) at the American Association for Cancer Research (AACR) Annual Meeting. This research has been selected to be featured in the meeting’s press program.

… Monday, April 3, 2017 Jae Park, MD , a hematologic oncologist and assistant attending physician at Memorial Sloan Kettering Cancer Center (MSK), will present findings about the durability of CAR T cell therapy response in patients with relapsed B-cell acute lymphoblastic leukemia (B-ALL) at the American

MSK Kids researchers publish report of screening and testing for COVID-19 in pediatric cancer patients in New York City.

… Wednesday, May 13, 2020 Researchers from MSK Kids at Memorial Sloan Kettering Cancer Center (MSK) found that children with cancer are not at a higher risk of being affected by COVID-19. This new research led by Andrew Kung, MD, PhD, Chair of MSK Kids and his colleagues was published today in JAMA Oncology

An analysis of patients who received molecular testing at MSK has found that about half of those with hereditary gene mutations could benefit from treatment with therapies that target those alterations.

… Wednesday, June 16, 2021 The majority of cancers are caused by random genetic changes and environmental exposures — things like sunlight, tobacco smoke, and the human papillomavirus (HPV). But Memorial Sloan Kettering researchers have found that, at least among people with metastatic or recurrent disease

Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2022. Here are some of the most important developments.

… Wednesday, December 14, 2022 Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2022. Clinical trials reported results of cutting-edge treatments, including new types of immunotherapy , radiation therapy , and experimental targeted